Answers are grounded in this paper and cite their sources.
Abstract Objective: To evaluate if there is a survival benefit of primary tumor treatment in uveal melanoma by comparing patients who declined treatment (Natural History Study, NHS) with those who received treatment in the Collaborative Ocular Melanoma Study (COMS) for medium-sized choroidal melanomas. Design: Retrospective cohort study using reverse-engineered survival data based on the original COMS publication. Subjects: A total of 1317 patients from the COMS cohort and 42 patients from the NHS cohort who declined treatment. Of the 42 NHS patients, 22 later opted for treatment after a mean delay of 1.4 years. Methods/Intervention: Kaplan-Meier survival curves were generated, and survival distributions between the NHS and COMS cohorts were compared using the Log-rank (Mantel-Cox) test. Main Outcome Measure: Survival difference between the COMS and NHS cohorts, assessed using Kaplan-Meier estimates of cumulative all-cause mortality. Results: After reverse-engineering the COMS and NHS cohorts and adjusting to reduce the risk of type I errors, we observed a hazard ratio for all-cause mortality of 1.72 (95% CI, 1.08–2.77) and an unadjusted risk ratio for death at 8 years of 1.48 (95% CI, 0.82–2.11). Both ratios were lower than those reported in the original publication, indicating a smaller survival difference. The reduction in the number of deaths in our reverse-engineered NHS cohort—18 compared to 19 in the original study—further supports the conservative nature of our approach. Nonetheless, Kaplan-Meier analysis revealed a significantly higher cumulative proportion of deaths in the NHS cohort (Log-rank P=0.02), despite these patients having smaller tumors at baseline. Conclusions: Patients who declined treatment in the NHS cohort had significantly worse survival outcomes than those in the COMS cohort, supporting the hypothesis that primary tumor treatment confers a survival benefit in uveal melanoma.
No takes yet. Share an insight, caveat, or question.
Witzenhausen et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: